Global Viscosupplementation Injection Market Research Report 2023(Status and Outlook)
Report Overview
Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.
Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
The classification of Viscosupplementation Injection includes Single Injection, Three Injection, Five Injection, and the sales share of Single Injection take about 40%.
Viscosupplementation Injection is widely used in hospitals, clinics and other place. The most proportion of Viscosupplementation Injection used in Hospitals, and the proportion is 55%.
North America is the largest consumption place, with a consumption market share nearly 52%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28%.
Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 63% market share.
The Global Viscosupplementation Injection Market Size was estimated at USD 1139.90 million in 2022 and is projected to reach USD 1680.32 million by 2029, exhibiting a CAGR of 5.70% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Viscosupplementation Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viscosupplementation Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viscosupplementation Injection market in any manner.
Global Viscosupplementation Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Market Segmentation (by Type)
Single Injection
Three Injection
Five Injection
Market Segmentation (by Application)
Automotive
Transportation
Machinery Manufacturing
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Viscosupplementation Injection Market
Overview of the regional outlook of the Viscosupplementation Injection Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors